Company: LGN
Filing Date: 2025-04-30
Form Type: DRS/A
Source: 0000950123-25-003868
Chunk: 103

Company: Legence Corp.
Filing Date: 2025-04-30
Form: DRS/A
Chunk 103
---
 payment of dividends. Such restrictions allow us to pay dividends after the completion of
this offering only when certain conditions are met, including but not limited to compliance with certain dollar baskets, ratio tests and the absence of certain specified events of default. See the section entitled “Management’s Discussion
and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Debt.”

See “Risk
Factors—Risks Related to Our Class A Common Stock and Structure— We do not intend to pay dividends following the completion of this offering and may never pay dividends” and “Management’s Discussion and Analysis of
Financial Condition and Results of Operations—Liquidity and Capital Resources.”

64

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 CAPITALIZATION The following table sets forth our cash position and capitalization as of December 31, 2024:

| • |     | on an actual basis for our predecessor; and |

| • |     | on an as adjusted basis to give effect to the reorganization described under “Corporate Reorganization”                                                                                                                           
 and this share offering at an assumed initial public offering price of $    per share (the midpoint of the range set forth on the cover of this prospectus), including the application of the net proceeds as set forth under the 
 section titled “Use of Proceeds.”                                                                                                                                                                                                 |

The information set forth in the table below is illustrative only and will be adjusted based on the actual initial public offering price and other final terms of this offering. This table should be read in conjunction with, and is qualified in its entirety by reference to, the “Use of Proceeds” section and our financial statements and related notes appearing elsewhere in this prospectus.

|                                                                                     |     | As of December 31, 2024      |           |   |     |                |   |
|:------------------------------------------------------------------------------------|:----|:-----------------------------|----------:|:--|:----|:---------------|:--|
|                                                                                     |     | Actual                       |           |   |     | As Adjusted(1) |   |
|                                                                                     |     | -in thousands, except shares 
 and par value                |           |   |     |                |   |
| Cash and cash equivalents                                                           |     | $                            |    81,167 |   |     | $              |   |
| Long-term debt:                                                                     |     |                              |           |   |     |